To study synthesis, storage, and secretion of brain natriuretic peptide (BNP) in the heart, we have measured BNP mRNA and BNP concentrations in the hearts of Wistar-Kyoto rats and also have investigated its secretion from the isolated perfused heart. The atrium expressed the BNP gene at a high level, and a considerable amount of BNP mRNA also was present in the ventricle, which corresponded to approximately 40%o of the atrial BNP mRNA concentration. When tissue weight was taken into account, the total content of BNP mRNA in the ventricle was approximately threefold larger than that in the atrium, although the atrial natriuretic peptide (ANP) mRNA content in the ventricle was only 7% of that in the atrium. By contrast, the BNP concentration in the ventricle was 4.07±0.97 pmol/g, which was less than 1% of that in the atrium (451±86 pmollg). The basal secretory rate of BNP from the isolated perfused whole heart was 49.3+±6.1 fmol/min, approximately 60%o of which was maintained even after atrial removal, whereas the secretory rate of ANP was reduced to less than 5%. We also studied age-matched spontaneously hypertensive rats-stroke prone. The rank order of the BNP mRNA concentration in the hearts of these rats was left ventricle>right ventricle> right atrium=left atrium, and the total BNP mRNA content and BNP secretory rate in the ventricle were twice as large as in Wistar-Kyoto rats. These results demonstrate that BNP is a novel cardiac hormone in rats and is predominantly synthesized in and secreted from the ventricle. This is in striking contrast to ANP, which occurs mainly in the atrium. 
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T he initial discovery by de Bold et all that atrial extracts possess potent natriuretic and diuretic properties led to the identification of atrial natriuretic peptide (ANP) in human and rat and is secreted as a cardiac hormone.14 However, the antisera against porcine BNP failed to detect any immunoreactivities in human and rat tissues, suggesting structural differences of BNP among species. We and others have isolated rat BNP from the atrium and determined its sequence with 45 amino acids,15-'8 which is identical to the carboxy-terminal sequence Northern blot analysis using the rat BNP cDNA probe identified a single 0.9 kb mRNA species in bilateral rat atria and ventricles ( Figure 1A) . The density or radioactivity in the hybridized band showed a linear relation with the amount of RNA applied to the electrophoresis gel. Table 2 summarizes tissue concentrations and total contents of BNP and ANP and their mRNAs in the heart of 12-weekold WKY rats. The rank order of the BNP mRNA concentration in the rat heart was right atrium>left atrium>left ventricle>right ventricle. The BNP mRNA concentration in the whole atrium was 2.4 times higher than that in the whole ventricle, whereas the ANP mRNA concentration in the whole atrium was approximately two orders of magnitude higher than that in the whole ventricle. The BNP mRNA concentration in the right atrium tended to be higher than the left atrial concentration, which was roughly parallel to the results on ANP mRNA concentrations in right and left atria. A than that in the whole atrium. By contrast, the ANP mRNA concentration in the whole ventricle was less than 1% of the atrial ANP mRNA concentration in the same sample; therefore, the total ventricular ANP mRNA content was only 7% of the total atrial content, as we previously reported. 24 The BNP mRNA concentration in the left ventricle was 3.3 times higher than that in the right ventricle. Thus, the BNP mRNA content in the left ventricle was one order of magnitude larger than that in the right ventricle. The ANP mRNA concentration in the left ventricle was five times higher than that in the right ventricle. As shown in Table 3 , the BNP mRNA/ANP mRNA ratio in the whole atrium was one order of magnitude lower than that in the whole ventricle. No substantial difference in the BNP mRNA/ANP mRNA ratio was observed between bilateral atria and between bilateral ventricles.
Brain Natriuretic Peptide Concentration in Rat Heart
Tissue concentrations and total contents of BNP and ANP were measured simultaneously by their specific RIAs in the heart of WKY rats at 12 weeks of age ( Table 2 ). The rank order of the BNP concentration in the rat heart was right atrium>left atrium> >left ventricle>right ventricle. The BNP concentration in the whole atrium was two orders of magnitude higher than that in the whole ventricle. The BNP concentration in the right atrium was slightly higher than that in the left atrium, which was comparable to the results on ANP concentrations in bilateral atria. The BNP concentration in the whole ventricle was 0.9% of that in the whole atrium; therefore, the BNP content in the whole ventricle was 7.0% of that in the whole atrium. In the same sample, the ANP concentration in the whole ventricle was less than 0.01% of that in the whole atrium; thus, the ventricular ANP content was only 0.5% of the atrial content. The BNP concentration in the left ventricle was approximately six times higher than that in the right ventricle. Thus, the BNP content in the left ventricle was approximately 30 times larger than that in the right ventricle. The ANP concentration in the left ventricle was four times higher than that in the right ventricle. The BNP/ANP ratio in the whole ventricle was much greater than that in the Figure 2A illustrates the time course of BNP and ANP secretory rates from isolated perfused hearts of 12-week-old WKY rats before and after atrial removal. The results are summarized briefly in Table 4 . The basal secretory rate of BNP from the perfused whole heart was 49.3+±6.1 fmollmin, which was approximately 8% of that of ANP. The ANP secretory rate was reduced to less than 5% within 10 minutes after atrial removal. Even after atrial removal, however, the BNP secretory rate was still as much as approximately 60% of its basal secretory rate from the whole heart. Therefore, the relative contribution of the ventricle to secretion of BNP from the whole heart was approximately 60%, whereas the relative contribution of the ventricle to secretion of ANP was less than 5%. Following the calculation described in the Table 4 legend, the secretory rate of BNP from the atrium was 20.4±3.1 fmol/min, whereas that of ANP was 626.1±87.4 fmol/min. The BNP/ANP ratio in the perfusate derived from the ventricle (110%) was much higher than that derived from the atrium (3.3%).
Brain Natriuretic Peptide Gene Expression in SHRSP Heart Total RNA extracted from atria and ventricles of SHRSPs contained a hybridizing RNA band of the same size of BNP mRNA from cardiac tissues of WKY rats ( Figure 1B) . Table 5 summarizes tissue concentrations and total contents of BNP and ANP and their mRNAs in the hearts of 12-week-old SHRSPs. The rank order of the BNP mRNA concentration in SHRSP heart was left ventricle>right ventricle>right atrium=left atrium. The BNP mRNA concentration in the whole atrium was approximately 30% of that in the whole ventricle, whereas the ANP mRNA concentration in the whole atrium was 1.4 times higher than that in the whole ventricle. The BNP mRNA concentration in the right atrium was very similar to that in the left atrium, which was comparable to the ANP mRNA concentrations in bilateral atria. The BNP mRNA concentration in the whole ventricle exceeded that in the whole atrium (360%); thus, the BNP mRNA content in the ventricle reached up to as much as 97% of that in the whole heart. In the same sample, the ANP mRNA concentration in the whole ventricle was 72% of that in the whole atrium, and the ANP mRNA content in the whole ventricle represented 88% of that in the whole heart. The BNP mRNA concentration in the left ventricle was 2.5 times higher than that in the right ventricle; thus, the BNP mRNA content in the left ventricle was one order of magnitude larger than that in the right ventricle. These results were parallel to those on the ANP mRNA concentrations in bilateral ventricles. As shown in Table 3 , the BNP mRNA/ANP mRNA ratio in the whole ventricle was five times higher than that in the whole atrium, and no substantial difference was observed bilaterally. As compared with Tables 2 and 5), the BNP mRNA and ANP mRNA concentrations in the whole atrium were reduced to 20% and 30%, respectively, and this tendency was observed bilaterally.
However, the BNP mRNA concentration in the whole ventricle of SHRSPs was 1.7 times higher than that in the whole ventricle of WKY rats, and these increases were observed bilaterally. Thus, the BNP mRNA content in the SHRSP whole ventricle was twice as large as that in the WKY whole ventricle. In the same sample, the ANP mRNA concentration in the SHRSP whole ventricle was 30 times higher than that in the WKY whole ventricle, as we previously reported. 24 Brain Natriuretic Peptide Concentration in
SHRSP Heart
The rank order of the BNP concentration in SHRSP heart was right atrium=left atrium>left ventricle>right ventricle (Table 5 ). The BNP concentration in the whole atrium was one order of magnitude higher than that in the whole ventricle, whereas the ANP concentration in the whole atrium was approximately 170 times higher than that in the whole ventricle. No apparent difference was discerned between bilateral atrial BNP concentrations as well as between bilateral atrial ANP concentrations. The BNP concentration in the whole ventricle was 2.9% of that in the whole atrium, and thus, the total ventricular BNP content represented 30% of the total atrial content. The BNP concentration in the left ventricle was four times higher than that in the right ventricle, which was roughly parallel to the results on the ANP concentrations in bilateral ventricles. As shown in Table 3 , the BNP/ANP ratio in the whole ventricle was five times higher than that in the whole atrium, and no substantial difference was observed bilaterally. The BNP and ANP concentrations in bilateral SHRSP atria were similar to those of WKY atria (see Tables 2 and 5 ). However, the BNP concentration in the whole ventricle showed a threefold increase, whereas the ANP concentration in the SHRSP whole ventricle was approximately nine times higher than that of WKY whole ventricle. This tendency was observed bilaterally.
Brain Natriuretic Peptide Secretion From Isolated Perfused SHRSP Heart Figure 2B shows the time course of BNP and ANP secretory rates from the isolated perfused hearts of SHRSPs before and after atrial removal. The basal secretory rate of BNP from the SHRSP perfused whole heart was 1.7 times greater than that from WKY hearts, which was comparable to the results on ANP ( Table 4) . As much as 85% of the BNP secretory rate was observed even after atrial removal, whereas the basal ANP secretory rate was reduced to approximately 70%. Thus, the relative contribution of the ventricle to secretions of BNP and ANP from the whole heart was 85% and 70%, respectively. As shown in Table 4 , the secretory rate of BNP from SHRSP ventricle was 2.4 times higher than that from WKY ventricle, whereas the secretory rate of ANP from SHRSP ventricle increased by 25-fold. The secretory rate of BNP from the atrium of SHRSPs decreased to 60% of that from the atrium of WKY rats, and in the same sample the ANP secretory rate decreased to 50%. The BNP/ANP ratio in the perfusate derived from the atrium was 4.0%, and that from the ventricle was 10%. Synthesis, Storage, and Secretion of Brain Natriuretic Peptide in WKY and SHRSP Hearts Figure 3 summarizes synthesis (mRNA content), storage (peptide content), and secretion (secretory rate) of BNP and ANP in WKY and SHRSP hearts. The mRNA content, peptide content, and secretory rate of BNP and ANP in the ventricle are expressed relative to those in the atrium (the atrial values are arbitrarily defined as 100%). In WKY hearts ( Figure  3A) , although the amount of BNP stored in the ventricle is small (7% of that in the atrium), a significant amount of BNP is synthesized in and secreted from the ventricle. In contrast, most of the synthesis (93.5%), storage (99.5%), and secretion (96.2%) of ANP occur in the atrium.
In SHRSP hearts ( Figure 3B ), BNP synthesis and secretion in the ventricle increase and reach up to 3,900% and 550% of the corresponding atrial values, respectively (exaggerated partly because the BNP synthesis and secretion are attenuated in the atrium of SHRSPs). ANP synthesis and secretion in the ventricle reach up to 750% and 210% of those in the atrium, respectively. BNP/BNP mRNA and ANP/ANP mRNA Concentration Ratios in WKY and SHRSP Atria and Ventricles Table 6 shows BNP/BNP mRNA and ANP/ANP mRNA concentration ratios in WKY and SHRSP atria and ventricles. The BNP/BNP mRNA concentration ratios in WKY and SHRSP atria were approximately 50 and 100 times higher than those in ventricles of the corresponding strains, respectively. The ANP/ANP mRNA concentration ratios in WKY and SHRSP atria were approximately 10 and 100 times higher than those in ventricles of the corresponding strains, respectively. The BNP/BNP mRNA or ANP/ANP mRNA concentration ratios were similar in bilateral ventricles as well as in bilateral atria in both strains. Discussion
Our previous studies demonstrated that BNP, originally isolated from the porcine brain as a putative neuropeptide,9 is hardly detectable in the rat brain and distributes only in the spinal cord1820; these previous studies also disclosed that the highest tissue concentration of BNP is present in the rat heart.1518220 In this context, the present study was designed to elucidate the synthesis, storage, and secretion of BNP in the rat heart in comparison with ANP.
The present study clearly demonstrates that BNP synthesis and secretion in the ventricle exceed those in the atrium. Although the atrium synthesizes a considerable amount of BNP (the BNP mRNA concentration in the atrium was 2.4 times higher than that in the ventricle), the total content of BNP mRNA in the ventricle was approximately three times larger than that in the atrium, thereby reaching up to approximately 75% of that in the whole heart.
To examine whether the ventricle secretes BNP at an amount comparable to its mRNA content, we investigated BNP secretion from the isolated rat heart perfused by the Langendorff method. Actually, approximately 60% of the total amount of BNP secreted from the isolated whole heart was derived from the ventricle. These findings indicate that BNP is predominantly synthesized in and secreted from the ventricle of the rat heart. In the present study, the ANP mRNA content in the atrium was two orders of magnitude larger than that in the ventricle, as we previously reported. 24 Furthermore, more than 95% of the total amount of ANP secreted from the whole heart was derived from the atrium. Therefore, the heart synthesizes and secretes two ligands of the natriuretic peptide family, ANP and BNP, the former produced mainly by the atrium and the latter mainly by the ventricle. In the present study, the BNP concentration in the ventricle was less than 1% of that in the atrium, although BNP mainly is synthesized in and secreted from the ventricle. In addition, the BNP/BNP mRNA concentration ratio in the atrium was approximately 50 times higher than that in the ventricle. These results indicate that BNP is secreted from the ventricle with a small capacity of storage. These results are consistent with our previous observations that the ANP/ANP mRNA concentration ratio in the ventricle is approximately one order of magnitude smaller than that in the atrium in rats24 and humans,27 as well as with the result of the pulse-chase experiment by Bloch et a135 that ventricular cardiocytes secrete ANP more rapidly via the constitutive pathway than atrial cardiocytes. These findings suggest that BNP also is secreted from the ventricle presumably via the constitutive pathway.
Although it may be difficult to make quantitative comparisons between BNP mRNA and ANP mRNA concentrations, Northern blot analysis in the present study has revealed that only a low amount of ANP mRNA could be detected in total RNA from the ventricle of WKY rats (even in 10 ,ug of total RNA from the ventricle) (data not shown), whereas a considerable amount of BNP mRNA could be detected readily in the same sample. Because the specific activity and length of the BNP cDNA probe are similar to those of the ANP cDNA probe in the present study, the amount of BNP mRNA should be larger than that of ANP mRNA in the ventricle, suggesting that the gene expression of BNP would exceed that of ANP in the ventricle. This may contradict the findings that the ANP concentration is slightly higher than the BNP concentration in the ventricle and that the BNP secretory rate is similar to the ANP secretory rate from the ventricle. One of the most characteristic features distinguishing BNP mRNA from ANP mRNA is the existence of a conserved sequence consisting of repeat units of AUUUA in the 3'-untranslated region of BNP mRNA of different species.1936-39 Shaw and Kamen40 demonstrated that this AU-rich sequence within the 3'-untranslated region of the granulocytemonocyte colony stimulating factor leads to rapid degradation of its mRNA. It is possible, therefore, that BNP mRNA is more unstable than ANP mRNA in cardiocytes and that a large amount of BNP mRNA is required to maintain its basal tissue level and secretion in the ventricle. Because the AU-rich sequence commonly is found in the 3'-untranslated region of mRNAs of various cytokines40,41 involved in autocrine and paracrine controls, it is conceivable that BNP serves not only as a cardiac hormone but also as an autocrine or paracrine regulator in the heart, where natriuretic peptide receptors have been demonstrated to be present. 42, 43 Another interesting finding in the present study is that the BNP/ANP ratio in the atrium agreed well with that in the perfusate derived from the atrium (4.6% versus 3.3% in WKY and 4.4% versus 4.0% in SHRSP atria) (Tables 3 and 4 ). This would raise the possibility that BNP and ANP are secreted from the atrium in the same ratio as they are stored in the atrium. It has been demonstrated that ANP is stored in secretory granules of mammalian atrial cardiocytes44, 45 and is released into the circulation in response to increased atrial pressure. 46 Although it is possible to speculate that BNP may coexist with ANP in atrial cardiocytes, probably in the same secretory granules, and be cosecreted with ANP in response to appropriate secretagogues, the subcellular localization and possible cosecretion of BNP and ANP in the atrium must await further investigation.
The present study also demonstrates that BNP synthesis and secretion are augmented in the ventricle of SHRSPs. The BNP mRNA concentration in the SHRSP ventricle was 1.7 times as high as that in WKY ventricle. Therefore, the total content of BNP mRNA in SHRSP ventricle was twice as large as that in WKY ventricle, which is consistent with the finding that the total amount of BNP secreted from SHRSP ventricle was 2.4 times larger than that in WKY ventricle. In the atrium of SHRSPs, however, BNP synthesis and secretion were attenuated, which may reflect the volume-contracted state in SHRSPs at the stage of established hypertension as reported elsewhere. 47 As a result, BNP secretion from SHRSP whole heart was 1.7 times greater than that from WKY whole heart. Together with our recent observations that the plasma human BNP concentration is increased in patients with various disorders, such as congestive heart failure and essential hypertension,4849 the present study suggests that BNP may play pathophysiological roles in hypertensive disorders and ventricular hypertrophy. In the present study, the ANP synthesis and secretion in SHRSP ventricle were approximately 30 times larger than those in WKY ventricle. Therefore, in the heart of SHRSPs, the predominant synthesis and secretion of BNP in the ventricle, as observed in the heart of WKY rats, are further exaggerated, whereas the major source of ANP in the heart shifts from the atrium to the ventricle. These observations suggest that the gene expressions of BNP and ANP are differently regulated in the heart. The genomic sequences of BNPs of some species recently have been analyzed, 39 and it has been found that the regulatory element that appears to control tissue-specific expression of human ANP (-400 to -333 at human ANP 5'-flanking sequence)50 is not present in the upstream sequence of the human BNP gene. Further studies are necessary to clarify how the gene expressions of BNP and ANP are regulated in the heart.
In conclusion, BNP is a novel cardiac hormone in rats and occurs predominantly in the ventricle, in striking contrast to ANP, which is mainly produced by the atrium. Recently, two types of natriuretic peptide receptors with guanylate cyclase activity and one type of receptor possibly involved in the clearance of natriuretic peptides have been cloned and sequenced. [51] [52] [53] Together with the differential regulation of BNP and ANP gene expression, these results suggest that BNP may play pathophysiological roles different from those of ANP in certain cardiovascular disorders.
